# CDH1 Germline Mutations in Lobular Breast Cancer

> **NCT04206891** · — · COMPLETED · sponsor: **European Institute of Oncology** · enrollment: 421 (actual)

## Conditions studied

- Lobular Breast Carcinoma
- CDH1 Gene Inactivation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04206891
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2025-11-26
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04206891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04206891, "CDH1 Germline Mutations in Lobular Breast Cancer". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT04206891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*